OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 30 07:05 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 9 13:24 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 4 06:35 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 2 07:04 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 29 14:32 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 22 07:01 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 21 07:06 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 20 08:12 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 9 07:04 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 31 07:01 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 8 00:00 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 00:00 ET
OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Dec 21, 2023 07:35 ET
OKYO Pharma | 424B5: Prospectus
Dec 20, 2023 17:30 ET
OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Dec 18, 2023 16:56 ET
OKYO Pharma | 424B5: Prospectus
Dec 15, 2023 17:46 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 4, 2023 07:00 ET
OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 29, 2023 07:00 ET
OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 1, 2023 16:55 ET
OKYO Pharma | 424B5: Prospectus
Oct 31, 2023 16:59 ET
No Data
No Data